1. Home
  2. TMDX vs SIGI Comparison

TMDX vs SIGI Comparison

Compare TMDX & SIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • SIGI
  • Stock Information
  • Founded
  • TMDX 1998
  • SIGI 1926
  • Country
  • TMDX United States
  • SIGI United States
  • Employees
  • TMDX N/A
  • SIGI N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SIGI Property-Casualty Insurers
  • Sector
  • TMDX Health Care
  • SIGI Finance
  • Exchange
  • TMDX Nasdaq
  • SIGI Nasdaq
  • Market Cap
  • TMDX 3.9B
  • SIGI 4.7B
  • IPO Year
  • TMDX 2019
  • SIGI N/A
  • Fundamental
  • Price
  • TMDX $107.79
  • SIGI $78.01
  • Analyst Decision
  • TMDX Buy
  • SIGI Hold
  • Analyst Count
  • TMDX 10
  • SIGI 7
  • Target Price
  • TMDX $122.11
  • SIGI $87.33
  • AVG Volume (30 Days)
  • TMDX 934.4K
  • SIGI 502.2K
  • Earning Date
  • TMDX 10-27-2025
  • SIGI 10-20-2025
  • Dividend Yield
  • TMDX N/A
  • SIGI 1.95%
  • EPS Growth
  • TMDX 2163.11
  • SIGI 66.75
  • EPS
  • TMDX 2.02
  • SIGI 6.11
  • Revenue
  • TMDX $531,292,000.00
  • SIGI $5,112,631,000.00
  • Revenue This Year
  • TMDX $38.86
  • SIGI $5.66
  • Revenue Next Year
  • TMDX $20.79
  • SIGI $6.95
  • P/E Ratio
  • TMDX $53.44
  • SIGI $12.75
  • Revenue Growth
  • TMDX 48.09
  • SIGI 12.30
  • 52 Week Low
  • TMDX $55.00
  • SIGI $71.75
  • 52 Week High
  • TMDX $169.29
  • SIGI $103.56
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 39.83
  • SIGI 45.03
  • Support Level
  • TMDX $101.00
  • SIGI $77.63
  • Resistance Level
  • TMDX $117.96
  • SIGI $81.10
  • Average True Range (ATR)
  • TMDX 5.07
  • SIGI 1.33
  • MACD
  • TMDX -1.15
  • SIGI 0.28
  • Stochastic Oscillator
  • TMDX 31.08
  • SIGI 19.95

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About SIGI Selective Insurance Group Inc.

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.

Share on Social Networks: